156 related articles for article (PubMed ID: 4899869)
1. Biology and pathogenicity of microbial spheroplasts and l-forms.
Feingold DS
N Engl J Med; 1969 Nov; 281(21):1159-70. PubMed ID: 4899869
[No Abstract] [Full Text] [Related]
2. L forms, spheroplasts and aberrant forms in chronic sepsis.
Louria DB
Adv Intern Med; 1971; 17():125-42. PubMed ID: 4126005
[No Abstract] [Full Text] [Related]
3. Staphylococcal spheroplasts and L-colonies. 3. Induction by lysostaphin.
Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
J Infect Dis; 1969 Jan; 119(1):67-74. PubMed ID: 5765044
[No Abstract] [Full Text] [Related]
4. Role of cell-wall-defective microbial variants in human infections.
Kenny JF
South Med J; 1978 Feb; 71(2):180-90. PubMed ID: 341340
[No Abstract] [Full Text] [Related]
5. [Spheroplasts, protoplasts and L form bacteria, their possible role in infection processes].
Porres FM
Rev Med Univ Navarra; 1973 Dec; 17(4):311-24. PubMed ID: 4807213
[No Abstract] [Full Text] [Related]
6. Spheroplasts, protoplasts, L-forms and pleuropneumonia-like organisms in disinfection studies.
Russell AD
Lab Pract; 1968 Jul; 17(7):804-8. PubMed ID: 5661218
[No Abstract] [Full Text] [Related]
7. Bacteria with their coats off: spheroplasts, protoplasts and L-forms.
Smith DG
Sci Prog; 1969; 57(226):169-92. PubMed ID: 4893484
[No Abstract] [Full Text] [Related]
8. Electron microscopy and viability of lysostaphin-induced staphylococcal spheroplasts, protoplast-like bodies, and protoplasts.
Schuhardt VT; Huber TW; Pope LM
J Bacteriol; 1969 Jan; 97(1):396-401. PubMed ID: 5764340
[TBL] [Abstract][Full Text] [Related]
9. Bacterial L-forms.
Allan EJ; Hoischen C; Gumpert J
Adv Appl Microbiol; 2009; 68():1-39. PubMed ID: 19426852
[TBL] [Abstract][Full Text] [Related]
10. [Microbiological study of spheroplasts from pathogenic Pseudomonas produced by antibiosis at the cell wall and membrane levels].
Pérez-Ureña MT; Espinosa M; Barasoain I; Portolés A
Microbiol Esp; 1974; 27(3-4):235-55. PubMed ID: 4217871
[No Abstract] [Full Text] [Related]
11. Staphylococcal spheroplasts and L colonies. IV. Antimicrobial susceptibility of stable methicillin-induced and lysostaphin-induced spheroplasts.
Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
Antimicrob Agents Chemother (Bethesda); 1968; 8():382-7. PubMed ID: 5195739
[No Abstract] [Full Text] [Related]
12. [Current thoughts on the L forms of bacteria. Their relations with the course of infectious diseases].
Ravina A
Presse Med (1893); 1969 Feb; 77(6):201-2. PubMed ID: 4977627
[No Abstract] [Full Text] [Related]
13. [Pathogenicity of L forms and spheroblasts in chronic urinary tract infection during childhood].
Daschner F
Zentralbl Bakteriol Orig A; 1974; 227(1-4):327-30. PubMed ID: 4154605
[No Abstract] [Full Text] [Related]
14. [Treatment of urinary tract infections].
Nowak H
Wiad Lek; 1973 May; 26(10):939-43. PubMed ID: 4575839
[No Abstract] [Full Text] [Related]
15. Lysostaphin-induced, osmotically fragile Staphylococcus aureus cells.
Huber TW; Schuhardt VT
J Bacteriol; 1970 Jul; 103(1):116-9. PubMed ID: 5423366
[TBL] [Abstract][Full Text] [Related]
16. L-forms--pathogenic or not?
Lancet; 1972 Jan; 1(7742):130-1. PubMed ID: 4108988
[No Abstract] [Full Text] [Related]
17. Clinico-microbiological studies on L-forms of bacteria in chronic pyelonephritis.
Shultsev GP; Burtsev WI; Kochemasova EN; Kassirskaya NG; Bakanova DI; Yudina II; Hamidora GH
Mater Med Pol; 1975; 7(2):114-8. PubMed ID: 1142822
[No Abstract] [Full Text] [Related]
18. The revival of micro-organisms sublethally injured by chemical inhibitors.
Gilbert P
Soc Appl Bacteriol Symp Ser; 1984; (12):175-97. PubMed ID: 6208618
[No Abstract] [Full Text] [Related]
19. [Altered forms of microorganisms and human pathology].
Timakov VD; Levashev VS
Sov Med; 1972 Apr; 35(4):3-6. PubMed ID: 4662446
[No Abstract] [Full Text] [Related]
20. Composition of bacterial cell walls in relation to antibiotic action.
Perkins HR
Adv Pharmacol Chemother; 1969; 7():283-307. PubMed ID: 4910169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
